Kuleon

Drug discovery company that utilizes AI-based technology to identify novel serotonergic drugs for targeted treatments

placeSeattle, Washington, United States calendar_todayFounded 2021 groups5 employees language kuleonbio.com

Innovation

10 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 425 times.

YearFilings
20234
20246
20257
20261

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon